Inclusion and diversity in clinical trials: Actionable steps to drive lasting change

被引:90
作者
Kelsey, Michelle D. [1 ,2 ]
Patrick-Lake, Bray [3 ]
Abdulai, Raolat [4 ]
Broedl, Uli C. [5 ]
Brown, Adam [6 ]
Cohn, Elizabeth [7 ]
Curtis, Lesley H. [2 ,8 ]
Komelasky, Chris [9 ]
Mbagwu, Michael [10 ]
Mensah, George A. [11 ]
Mentz, Robert J. [1 ,2 ]
Nyaku, Amesika [12 ]
Omokaro, Stephanie O. [13 ]
Sewards, Judy [14 ]
Whitlock, Kendal [5 ]
Zhang, Xinzhi [15 ]
Bloomfield, Gerald S. [1 ,2 ]
机构
[1] Duke Univ, Dept Med, Div Cardiol, Durham, NC USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Evidat Hlth Inc, San Mateo, CA USA
[4] Sanofi, Cambridge, MA USA
[5] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[6] ClinArk, Dayton, OH USA
[7] CUNY, Hunter Coll, New York, NY 10021 USA
[8] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA
[9] SiteBridge, Chapel Hill, NC USA
[10] Verana Hlth, San Francisco, CA USA
[11] NHLBI, NIH, Bethesda, MD USA
[12] Rutgers New Jersey Med Sch, Dept Med, Div Infect Dis, Newark, NJ USA
[13] US FDA, Silver Spring, MD USA
[14] Pfizer Inc, New York, NY USA
[15] Natl Inst Minor Hlth & Hlth Dispar, NIH, Bethesda, MD USA
关键词
Diversity; Inclusion; Underrepresented populations; Clinical trials; MINORITIES; BARRIERS; CANCER; PARTICIPATION; FACILITATORS; RECRUITMENT; POPULATIONS; RETENTION; ETHNICITY; LITERACY;
D O I
10.1016/j.cct.2022.106740
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Improving diversity in clinical trials is essential in order to produce generalizable results. Although the importance of representation has become increasingly recognized, identifying strategies to approach this work remains elusive. This article reviews the proceedings of a multi-stakeholder conference about the current state of diversity in clinical trials and outlines actionable steps for improvement.Methods: Conference attendees included representatives from the United States Food and Drug Administration (FDA), National Institutes of Health (NIH), practicing clinical investigators, pharmaceutical and device companies, community-based organizations, data analytics companies, and patient advocacy groups. At this virtual event, attendees were asked to consider key questions around best practices for engagement of underrepresented populations.Results: Community engagement is an integral part of recruitment and retention of underrepresented groups. Decentralization of sites and use of digital tools can enhance the accessibility of clinical research. Finally, improving representation among investigators and clinical research staff may translate to diverse clinical trial participants.Conclusion: Improving diversity in clinical trials is an ethical and scientific imperative, which requires a multifaceted approach.
引用
收藏
页数:5
相关论文
共 46 条
[1]  
American College of Cardiology, CLIN TRIALS RES UPP
[2]   Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment [J].
Andrasik, Michele P. ;
Broder, Gail B. ;
Wallace, Stephaun E. ;
Chaturvedi, Richa ;
Michael, Nelson L. ;
Bock, Sally ;
Beyrer, Chris ;
Oseso, Linda ;
Aina, Jasmin ;
Lucas, Jonathan ;
Wilson, David R. ;
Kublin, James G. ;
Mensah, George A. .
PLOS ONE, 2021, 16 (10)
[3]   Henrietta Lacks: science must right a historical wrong [J].
不详 .
NATURE, 2020, 585 (7823) :7-7
[4]  
[Anonymous], 2021, Mob Fact Sheet
[5]  
[Anonymous], 2022, DCRI INSIGHTS THINK
[6]   Moving toward True Inclusion of Racial/Ethnic Minorities in Federally Funded Studies [J].
Burchard, Esteban G. ;
Oh, Sam S. ;
Foreman, Marilyn G. ;
Celedon, Juan C. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (05) :514-521
[7]  
Centers for Disease Control and Prevention, 2022, PRINC COMM ENG, V2nd
[8]   A Systematic Review of Community-Based Participatory Research to Enhance Clinical Trials in Racial and Ethnic Minority Groups [J].
De Las Nueces, Denise ;
Hacker, Karen ;
DiGirolamo, Ann ;
Hicks, LeRoi S. .
HEALTH SERVICES RESEARCH, 2012, 47 (03) :1363-1386
[9]   Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals [J].
Flanagin, Annette ;
Frey, Tracy ;
Christiansen, Stacy L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (07) :621-627
[10]   Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials [J].
Flores, Laura E. ;
Frontera, Walter R. ;
Andrasik, Michele P. ;
Del Rio, Carlos ;
Mondriguez-Gonzalez, Antonio ;
Price, Stephanie A. ;
Krantz, Elizabeth M. ;
Pergam, Steven A. ;
Silver, Julie K. .
JAMA NETWORK OPEN, 2021, 4 (02)